- Home
- CLWT vs IMRN Comparison
CLWT vs IMRN Comparison
Compare CLWT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLWT
- IMRN
- Stock Information
- Founded
- CLWT 1971
- IMRN 1994
- Country
- CLWT Hong Kong
- IMRN Australia
- Employees
- CLWT N/A
- IMRN N/A
- Industry
- CLWT Professional and commerical equipment
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CLWT Consumer Discretionary
- IMRN Health Care
- Exchange
- CLWT Nasdaq
- IMRN Nasdaq
- Market Cap
- CLWT 8.7M
- IMRN 9.2M
- IPO Year
- CLWT 1997
- IMRN N/A
- Fundamental
- Price
- CLWT $1.20
- IMRN $1.72
- Analyst Decision
- CLWT
- IMRN Strong Buy
- Analyst Count
- CLWT 0
- IMRN 1
- Target Price
- CLWT N/A
- IMRN $5.00
- AVG Volume (30 Days)
- CLWT 12.2K
- IMRN 668.0K
- Earning Date
- CLWT 04-30-2025
- IMRN 09-08-2025
- Dividend Yield
- CLWT N/A
- IMRN N/A
- EPS Growth
- CLWT N/A
- IMRN N/A
- EPS
- CLWT 0.10
- IMRN N/A
- Revenue
- CLWT $15,383,000.00
- IMRN $4,048,286.00
- Revenue This Year
- CLWT N/A
- IMRN N/A
- Revenue Next Year
- CLWT N/A
- IMRN N/A
- P/E Ratio
- CLWT $12.93
- IMRN N/A
- Revenue Growth
- CLWT N/A
- IMRN 82.90
- 52 Week Low
- CLWT $1.01
- IMRN $1.50
- 52 Week High
- CLWT $1.70
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- CLWT 40.83
- IMRN 44.34
- Support Level
- CLWT $1.17
- IMRN $1.57
- Resistance Level
- CLWT $1.30
- IMRN $1.71
- Average True Range (ATR)
- CLWT 0.05
- IMRN 0.07
- MACD
- CLWT -0.01
- IMRN -0.00
- Stochastic Oscillator
- CLWT 0.00
- IMRN 38.52
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.